Reimbursement Newsletter

RJ Health provides insight into new drugs and devices, code price updates and more as it applies to medically covered drugs.

Specialty Drug Reimbursement Newsletter | January 2026

January

16

2026

RJ Health, an MMIT company, delivers industry standard specialty drug pricing, coding and reimbursement solutions to support payer and provider alignment.

Every month, our team evaluates a variety of pricing and coding updates. In the January edition of the Specialty Drug Reimbursement Newsletter, we identified 99 drug code price changes this month, with 17 of them being price decreases. We have also identified drugs to be added or updated within our database. Preview some of these insights below:

This month, during our review of the 4306 Reimbursement HCPCS/CPT® Codes in our system, we identified 99 Drug Codes that required a recalculation of their AWP Code Price. Clients can log in to www.ReimbursementCodes.com to view the pricing updates for these codes.

90283 90627 A9513 B4157 J0875 J1644 J7193 J9202 Q2055
90284 90677 A9557 C9145 J0897 J1670 J7194 J9263 Q2057
90375 90678 A9558 E0570 J1200 J1817 J7197 J9266 Q4102
90380 90697 A9587 E0607 J1201 J2278 J7212 J9280 Q5127
90381 90698 A9591 J0185 J1430 J2290 J7300 J9281 Q5128
90384 91320 A9595 J0256 J1434 J2354 J7307 J9324 Q9957
90385 A4213 A9596 J0360 J1554 J2788 J7345 J9353 Q9983
90389 A4253 A9607 J0462 J1556 J2790 J7510 P9041 S0108
90621 A4614 A9800 J0615 J1558 J3030 J8541 P9045 S0138
90623 A7005 B4105 J0668 J1561 J3411 J9041 P9046 S0183
90626 A9512 B4155 J0706 J1627 J7186 J9118 Q2054 S0187

ReimbursementCodes was designed for organizations like yours to manage pricing, coding and clinical challenges related to specialty drugs. To gain access to this tool and view the rest of the insights we captured this month, visit our site or contact marketing@mmitnetwork.com.

Featured

From Compliance to Strategy: How Payers Are Refining Their IRA Playbooks

power-move-reshaping-pharma-access

Portfolio Contracting: The Power Move Reshaping Pharma Access

Market-Access-2026

Market Access in 2026: Predictions on DTC Programs, Biosimilars and GLP-1s

Stay In Touch

Be the first to know about new arrivals and promotions

Reducing Risk: 5 Steps for a Fearless Launch